<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Tayebjee MH</submitter><funding>Medtronic</funding><funding>Medtronic Inc</funding><pubmed_abstract>Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however it is not always successful and may accelerate VT requiring defibrillation. REVRAMP is a novel concept of ATP that involves delivering pacing at a faster rate than VT, but instead of abruptly terminating pacing after eight beats, pacing is gradually slowed until VT continues or normal rhythm is restored. In a pilot study we show that REVRAMP can restore normal rhythm, and that if REVRAMP is unsuccessful, VT is not accelerated.</pubmed_abstract><journal>Indian pacing and electrophysiology journal</journal><pagination>54-57</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8811284</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reverse RAMP (REVRAMP) pacing: A novel anti tachycardia pacing technique.</pubmed_title><pmcid>PMC8811284</pmcid><pubmed_authors>Holden AV</pubmed_authors><pubmed_authors>Tayebjee MH</pubmed_authors><pubmed_authors>Bowes R</pubmed_authors><pubmed_authors>Stegemann B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reverse RAMP (REVRAMP) pacing: A novel anti tachycardia pacing technique.</name><description>Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however it is not always successful and may accelerate VT requiring defibrillation. REVRAMP is a novel concept of ATP that involves delivering pacing at a faster rate than VT, but instead of abruptly terminating pacing after eight beats, pacing is gradually slowed until VT continues or normal rhythm is restored. In a pilot study we show that REVRAMP can restore normal rhythm, and that if REVRAMP is unsuccessful, VT is not accelerated.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan-Feb</publication><modification>2025-04-04T07:50:58.747Z</modification><creation>2025-04-04T07:50:58.747Z</creation></dates><accession>S-EPMC8811284</accession><cross_references><pubmed>34775047</pubmed><doi>10.1016/j.ipej.2021.11.001</doi></cross_references></HashMap>